Compare BEKE & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BEKE | ZBH |
|---|---|---|
| Founded | 2001 | 1927 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.8B | 18.7B |
| IPO Year | 2020 | N/A |
| Metric | BEKE | ZBH |
|---|---|---|
| Price | $16.17 | $90.77 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 20 |
| Target Price | $24.36 | ★ $107.00 |
| AVG Volume (30 Days) | ★ 4.1M | 2.1M |
| Earning Date | 11-10-2025 | 02-05-2026 |
| Dividend Yield | ★ 2.22% | 1.06% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.42 | ★ 4.03 |
| Revenue | ★ $14,540,474,652.00 | $8,010,900,000.00 |
| Revenue This Year | $6.97 | $7.98 |
| Revenue Next Year | $4.40 | $5.21 |
| P/E Ratio | $38.87 | ★ $22.51 |
| Revenue Growth | ★ 25.42 | 5.47 |
| 52 Week Low | $15.39 | $85.33 |
| 52 Week High | $25.17 | $114.44 |
| Indicator | BEKE | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 43.05 | 44.67 |
| Support Level | $15.83 | $88.50 |
| Resistance Level | $16.28 | $92.82 |
| Average True Range (ATR) | 0.29 | 1.88 |
| MACD | -0.06 | -0.10 |
| Stochastic Oscillator | 20.16 | 38.77 |
KE Holdings, or Beike, is a large residential real estate sales and rental brokerage company in China. Founded in 2001, the company operates through self-owned Lianjia stores in Beijing and Shanghai and connected third-party agencies, including franchise brand Deyou in other cities, with commissions charged on existing-home and new-home transactions. Leveraging an online-offline hybrid model, Beike also attract clients through its namesake online marketplace. The company tapped into home renovation services by acquiring Shengdu Home Decoration in 2022. As of the end of 2024, Beike's co-founders collectively control the company, while Tencent and its affiliates share 8% of voting power.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.